SpaceX’s expected 2026 IPO has millions of everyday investors asking the same question: is there a way in before it goes public? The answer is yes, and you do not need to be wealthy or accredited to do it. ETFs and interval funds now offer SpaceX exposure with entry points starting as low as one share of XOVR at ~$19, or $500 through ARK Venture Fund. This guide covers the best retail-friendly options, how they work, and what to watch out for.
Key takeaways:
- Non-accredited investors can access SpaceX through ETFs and interval funds
- XOVR offers the highest SpaceX concentration with no minimum beyond one share (~$19)
- ARK Venture Fund starts at $500, Private Shares Fund at $2,500
- Pre-IPO exposure through funds should remain a small, considered part of your portfolio
Do retail investors need accreditation to invest in SpaceX?
An accredited investor is someone with a net worth above $1 million excluding their primary home, or annual income of $200,000 or more. Secondary market platforms that sell private SpaceX shares directly require this status, with minimums typically starting at $100,000. For most retail investors, that door is firmly closed.
However, ETFs and interval funds operate under different SEC rules. They are legally open to all investors regardless of income or net worth, and some offer SpaceX exposure with minimums as low as $500. Accreditation is only a barrier if you want direct share ownership, not fund-based exposure.
What are the best retail-friendly ways to get SpaceX exposure?
Here are the most accessible options available to non-accredited investors today:
- XOVR ETF: Highest SpaceX concentration of any ETF at ~50%, held through an SPV. No minimum beyond one share (Approx. ~$19 but share price fluctuates daily with market conditions).
○ Daily liquidity on NASDAQ.
- RONB ETF: Holds direct SpaceX shares at ~9% exposure. No minimum beyond one share (~$23–24).
○ Daily liquidity on NYSE.
- ARK Venture Fund (ARKVX): SpaceX is the top holding at ~17% of the portfolio. Minimum $500 via SoFi or Titan.
○ Quarterly redemptions only.
- Private Shares Fund (PRIVX): SpaceX and xAI combined at ~19%. Minimum $2,500.
○ Quarterly repurchase offers.
- Alphabet (GOOGL): Indirect proxy play. Alphabet owns ~6% of SpaceX following a $900M investment in 2015.
○ Highly diluted but buyable for the price of one share.
| Option | Min. Investment | SpaceX Exposure | Liquidity | Best For |
| XOVR ETF | 1 share (Current Share Price: ~$19) | ~50% | Daily | Max concentration |
| RONB ETF | 1 share (Current Share Price: ~$23–24) | ~9% | Daily | Direct shares |
| ARK Venture (ARKVX) | $500 | ~17% | Quarterly | Long-term hold |
| Private Shares (PRIVX) | $2,500 | ~19% | Quarterly | Private equity exposure |
| Alphabet (GOOGL) | ~$1/share | Highly diluted | Daily | Indirect proxy |
Why is XOVR the most accessible option for retail investors?
XOVR is available on every major brokerage platform including Schwab, Fidelity, Robinhood, and E-Trade. There is no account minimum, no accreditation requirement, and no lock-up period. You can buy a single share for around $19 and sell it the next day if needed.
The fund holds SpaceX through an SPV, which means you are not a direct SpaceX shareholder, but you get daily tradable exposure to its valuation. With roughly 50% of the portfolio tied to SpaceX, no other retail-accessible vehicle comes close in terms of pure concentration. For a retail investor who simply wants the most SpaceX exposure possible for the least friction, XOVR is the straightforward answer.
Should retail investors wait for the IPO instead?
There is a reasonable case on both sides.
Reasons to buy pre-IPO exposure now:
- Lock in fund exposure at current valuations before the IPO pricing
- Capture any first-day pop, historically 30-100%+ for major tech IPOs.
- Avoid IPO day retail allocation uncertainty, SpaceX has promised 30% retail allocation but broker distribution is never guaranteed
Reasons to wait:
- Many high-profile IPOs drop 20-40% within the first few months post-listing
- Waiting gives access to public financials before committing
- Direct share ownership post-IPO means no fund fees
However, the balanced approach would be to open a small position through XOVR or RONB now, then reassess after seeing IPO day price action. Waiting 1-3 months post-listing for volatility to settle often leads to a better entry for direct buyers.
What risks should retail investors understand Before Investing?
- High valuation risk: At $1.75 trillion, SpaceX trades at 100x+ its 2025 revenues. Post-IPO corrections are a real possibility.
- Concentration risk: XOVR’s 50% SpaceX weighting means a single company drives most of its performance.
- Illiquidity in interval funds: ARKVX and PRIVX lock up capital quarterly and can suspend redemptions entirely.
- No direct shareholder rights: Fund investors have zero voting rights in SpaceX regardless of how much they invest.
- IPO delays or pricing volatility: The IPO timeline could shift, leaving pre-IPO fund holders waiting longer than expected with capital locked up.
How much SpaceX exposure should retail investors allocate?
Pre-IPO investing in a single private company should always be a small slice of a broader portfolio. A simple framework:
- Conservative investors: 2-5% of total portfolio
- Moderate investors: 5-10% of total portfolio
- Aggressive investors: Up to 10-15% maximum
Beyond 15%, concentration in a single pre-IPO position starts to carry risk that most retail investors are not positioned to absorb if valuations correct sharply post-listing.
What’s the simplest way for beginners to start?
Follow these five steps:
- Choose your vehicle: XOVR for maximum SpaceX exposure, ARKVX if you prefer a $500 minimum with a diversified fund
- Open or fund your brokerage account: XOVR and RONB are available on all major platforms
- Start small: $200-500 is a sensible starting point for a first position
- Use limit orders: Avoid market orders on ETFs with lower trading volumes like RONB
- Monitor quarterly, not daily: These are pre-IPO positions. Short-term price noise is expected and mostly irrelevant to the long-term thesis
Frequently Asked Questions
1. Can I invest in SpaceX before the IPO without accreditation?
Yes. ETFs like XOVR and RONB and interval funds like ARK Venture and Private Shares Fund are all open to non-accredited investors. Accreditation is only required for direct share purchases through secondary market platforms like Forge Global and EquityZen.
2. What’s the minimum investment needed for SpaceX exposure?
The lowest entry point is XOVR at roughly $19 per share, with no minimum beyond that. ARK Venture Fund starts at $500, and the Private Shares Fund requires $2,500 for Class A shares.
3. Which ETF has the highest SpaceX allocation?
XOVR holds the highest SpaceX concentration of any ETF at approximately 50% of its portfolio, through an SPV structure. It trades daily on NASDAQ and is available through all major brokerages.
4. Is XOVR better than ARK Venture for retail investors?
It depends on your priorities. XOVR offers higher SpaceX concentration, daily liquidity, and a lower entry point. ARK Venture offers more diversification across private tech companies but locks up capital quarterly and charges higher fees at 2.75%. XOVR suits investors who want flexibility, ARK suits those with a longer horizon.
5. Can retail investors get SpaceX IPO shares directly?
It is possible but not guaranteed. SpaceX has reportedly committed to a 30% retail allocation for its IPO, but actual broker distribution varies and retail investors often receive limited or no allocation for high-demand listings. ETFs and funds remain the more reliable pre-IPO route for most retail investors.
The above information does not constitute any form of advice or recommendation by London Loves Business and is not intended to be relied upon by users in making (or refraining from making) any finance decisions. Appropriate independent advice should be obtained before making any such decision. London Loves Business bears no responsibility for any gains or losses.





Leave a Comment